VOR
Another insider sale, another eyebrow raise
Vor Biopharma got a fresh SEC filing showing Director Ra Capital Management, L.P. sold 53,644 shares at an average price of $16.01 on Wednesday, April 15. The haul came out to $858,840.44.
Why investors care
Insider trades are a bit like peeking at the kitchen when the restaurant’s still open. One sale doesn’t tell you the whole menu, but it can still make you wonder what the people closest to the action are thinking.
In this case, the filing says the director still owns 3,197,619 shares worth roughly $51.2 million, so this wasn’t a full exit. The reported position dropped 1.65%, which is notable — but not exactly a dramatic “I’m out” moment.
The fine print
- This was disclosed in an SEC filing, which means it’s the real deal, not rumor mill theater.
- The sale happened at $16.01 a share.
- The key thing to watch is whether this is a one-off trim or the start of a pattern.
Big picture: insider selling can spook traders, but context matters. If the stake is still massive, this looks more like portfolio trimming than a fire alarm.